- Home
- FHTX vs EMO Comparison
FHTX vs EMO Comparison
Compare FHTX & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- EMO
- Stock Information
- Founded
- FHTX 2015
- EMO 2011
- Country
- FHTX United States
- EMO United States
- Employees
- FHTX N/A
- EMO N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- EMO Investment Managers
- Sector
- FHTX Health Care
- EMO Finance
- Exchange
- FHTX Nasdaq
- EMO Nasdaq
- Market Cap
- FHTX 513.7M
- EMO 547.7M
- IPO Year
- FHTX 2020
- EMO N/A
- Fundamental
- Price
- FHTX $5.14
- EMO $45.00
- Analyst Decision
- FHTX Strong Buy
- EMO
- Analyst Count
- FHTX 5
- EMO 0
- Target Price
- FHTX $13.80
- EMO N/A
- AVG Volume (30 Days)
- FHTX 197.3K
- EMO 27.1K
- Earning Date
- FHTX 11-04-2024
- EMO 01-01-0001
- Dividend Yield
- FHTX N/A
- EMO 6.70%
- EPS Growth
- FHTX N/A
- EMO N/A
- EPS
- FHTX N/A
- EMO N/A
- Revenue
- FHTX $25,515,000.00
- EMO N/A
- Revenue This Year
- FHTX N/A
- EMO N/A
- Revenue Next Year
- FHTX $11.54
- EMO N/A
- P/E Ratio
- FHTX N/A
- EMO N/A
- Revenue Growth
- FHTX N/A
- EMO N/A
- 52 Week Low
- FHTX $2.70
- EMO $26.42
- 52 Week High
- FHTX $10.25
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- FHTX 27.35
- EMO 39.33
- Support Level
- FHTX $4.69
- EMO $44.00
- Resistance Level
- FHTX $5.70
- EMO $48.00
- Average True Range (ATR)
- FHTX 0.61
- EMO 1.31
- MACD
- FHTX -0.14
- EMO -0.59
- Stochastic Oscillator
- FHTX 16.24
- EMO 16.81
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.